Insufficient scRNA-seq data for expression of APBA3 at single-cell level.
Insufficient scRNA-seq data for expression of APBA3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 847.80 | 1445 / 1445 | 100% | 10.16 | 183 / 183 |
ovary | 100% | 1233.18 | 180 / 180 | 100% | 8.98 | 430 / 430 |
uterus | 100% | 1099.99 | 170 / 170 | 100% | 10.45 | 458 / 459 |
thymus | 100% | 1190.91 | 653 / 653 | 100% | 9.95 | 603 / 605 |
stomach | 100% | 797.75 | 359 / 359 | 100% | 10.04 | 285 / 286 |
intestine | 100% | 962.23 | 966 / 966 | 100% | 9.87 | 525 / 527 |
kidney | 100% | 966.16 | 89 / 89 | 100% | 8.75 | 897 / 901 |
prostate | 100% | 1103.72 | 245 / 245 | 99% | 9.36 | 499 / 502 |
brain | 99% | 590.69 | 2622 / 2642 | 100% | 10.23 | 705 / 705 |
bladder | 100% | 957.48 | 21 / 21 | 99% | 10.10 | 500 / 504 |
lung | 100% | 930.29 | 577 / 578 | 99% | 8.85 | 1146 / 1155 |
skin | 100% | 845.55 | 1808 / 1809 | 99% | 10.76 | 466 / 472 |
pancreas | 100% | 576.22 | 327 / 328 | 99% | 9.22 | 176 / 178 |
breast | 100% | 912.50 | 459 / 459 | 99% | 8.28 | 1102 / 1118 |
liver | 100% | 717.77 | 226 / 226 | 99% | 8.28 | 400 / 406 |
adrenal gland | 100% | 798.34 | 258 / 258 | 98% | 6.88 | 226 / 230 |
adipose | 100% | 811.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 7.64 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.42 | 29 / 29 |
spleen | 100% | 1474.92 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.47 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.16 | 1 / 1 |
muscle | 100% | 935.26 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 745.44 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 606.98 | 855 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1024.23 | 921 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015031 | Biological process | protein transport |
GO_0010468 | Biological process | regulation of gene expression |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0001701 | Biological process | in utero embryonic development |
GO_0043086 | Biological process | negative regulation of catalytic activity |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0019899 | Molecular function | enzyme binding |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | APBA3 |
Protein name | Amyloid-beta A4 precursor protein-binding family A member 3 (Adapter protein X11gamma) (Neuron-specific X11L2 protein) (Neuronal Munc18-1-interacting protein 3) (Mint-3) |
Synonyms | MINT3 X11L2 |
Description | FUNCTION: May modulate processing of the amyloid-beta precursor protein (APP) and hence formation of APP-beta. May enhance the activity of HIF1A in macrophages by inhibiting the activity of HIF1AN. . |
Accessions | ENST00000316757.4 O96018 |